6.1 Shock Classification, Cellular Pathophysiology & Biomarkers

Definition and Cellular Dysoxia

Circulatory shock is defined as a life-threatening, generalized maldistribution of blood flow resulting in the failure of cellular oxygen delivery ($\text{DO}_2$) to satisfy cellular metabolic oxygen consumption ($\text{VO}_2$). The cardinal pathophysiological consequence of shock is cellular dysoxia—a state in which mitochondrial oxidative phosphorylation is constrained by inadequate oxygen availability, triggering energetic failure, cell injury, and multi-organ dysfunction syndrome (MODS).

Under basal physiological conditions, global oxygen delivery exceeds oxygen consumption by a factor of three to four:

$\text{DO}_2 = \text{CO} \times \text{CaO}_2 = \text{CO} \times \left( 1.34 \times \text{Hb} \times \text{SaO}_2 + 0.003 \times \text{PaO}_2 \right)$

$\text{VO}_2 = \text{CO} \times \left( \text{CaO}_2 - \text{CvO}_2 \right)$

Where $\text{CO}$ is cardiac output, $\text{CaO}_2$ is arterial oxygen content, $\text{CvO}_2$ is mixed venous oxygen content, $\text{Hb}$ is hemoglobin concentration, and $\text{SaO}_2$ is arterial oxygen saturation. In healthy resting adults, $\text{DO}_2$ is approximately $1000\text{ mL/min}$ ($500-600\text{ mL/min/m}^2$) and $\text{VO}_2$ is approximately $250\text{ mL/min}$ ($110-160\text{ mL/min/m}^2$), yielding a normal oxygen extraction ratio ($\text{O}_2\text{ER} = \text{VO}_2 / \text{DO}_2$) of $25\%$ to $30\%$.

When $\text{DO}_2$ declines (due to hypovolemia, myocardial depression, or severe anemia), tissues maintain constant oxygen consumption by progressively increasing the oxygen extraction ratio up to $60-70\%$. However, when $\text{DO}_2$ falls below a critical threshold (termed the critical oxygen delivery, $\text{DO}_{2\text{crit}}$), tissue extraction capacity becomes exhausted. Beyond this tipping point, cellular oxygen consumption becomes supply-dependent, intracellular adenosine triphosphate (ATP) production plummets, and cells transition to anaerobic glycolysis.

At the cellular level, the loss of mitochondrial ATP generation impairs membrane ion homeostatic pumps, most notably the $\text{Na}^+/\text{K}^+$-ATPase and the $\text{Ca}^{2+}$-ATPase. Intracellular sodium and water accumulation induce cytotoxic edema and cellular swelling, while cytosolic calcium overload activates endogenous proteases, phospholipases, and endonucleases. The mitochondrial permeability transition pore (mPTP) opens, collapsing the mitochondrial membrane potential, releasing cytochrome c into the cytosol, and initiating programmed apoptotic and necrotic cell death pathways.

---

The Four Classic Shock Categories

Shock is clinically categorized into four fundamental pathophysiological phenotypes: hypovolemic, cardiogenic, distributive, and obstructive shock. While patient presentations in the intensive care unit frequently exhibit mixed shock features (such as septic shock complicated by hypovolemia and septic cardiomyopathy), mastering the pure profiles provides the foundation for hemodynamic diagnosis.

1. Hypovolemic Shock

Hypovolemic shock results from a critical loss of effective circulating intravascular volume, reducing venous return (mean systemic filling pressure) to the right atrium and diminishing end-diastolic ventricular filling.

• Hemorrhagic Etiologies: Blunt or penetrating trauma, gastrointestinal bleeding, ruptured abdominal aortic aneurysm, retroperitoneal hemorrhage, ruptured ectopic pregnancy, or surgical bleeding.
• Non-Hemorrhagic Etiologies: Severe gastrointestinal volume loss (cholera, intractable vomiting, profuse diarrhea), renal wasting (diabetic ketoacidosis, hyperosmolar hyperglycemic state, high-dose diuretic therapy, salt-wasting nephropathies), severe burns (thermal injury causing diffuse capillary extravasation), and internal fluid sequestration/third-spacing (acute pancreatitis, bowel obstruction, crush injury).
• Hemodynamic Profile: Central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP) are markedly reduced. Stroke volume and cardiac output are severely depressed. In response to arterial baroreceptor de-activation, massive sympathetic discharge drives compensatory arterial vasoconstriction, resulting in elevated systemic vascular resistance ($SVR > 1200\text{ dynes}\cdot\text{sec}\cdot\text{cm}^{-5}$) and narrow pulse pressure ($< 30\text{ mmHg}$). Extremities are typically cool, clammy, and show delayed capillary refill ($> 3\text{ seconds}$).

2. Cardiogenic Shock

Cardiogenic shock is characterized by primary circulatory pump failure resulting in inadequate cardiac output despite adequate or elevated ventricular intravascular filling pressures.

• Myopathic Etiologies: Acute myocardial infarction involving $> 40\%$ of left ventricular myocardium, acute ischemic stunning, fulminant viral or autoimmune myocarditis, end-stage dilated cardiomyopathy, stress (Takotsubo) cardiomyopathy, or severe post-cardiac arrest myocardial stunning.
• Arrhythmogenic Etiologies: Sustained ventricular tachycardia, ventricular fibrillation, refractory rapid atrial fibrillation/flutter in non-compliant ventricles, or high-grade atrioventricular block and severe bradyarrhythmias.
• Mechanical Etiologies: Acute mitral regurgitation secondary to papillary muscle rupture or chordal rupture, acute ventricular septal defect (VSD), free wall rupture, severe acute aortic insufficiency (due to infective endocarditis or acute aortic dissection), or critical aortic stenosis.
• Hemodynamic Profile: Cardiac index is severely depressed ($CI < 2.2\text{ L/min/m}^2$, or $< 1.8\text{ L/min/m}^2$ without support). Ventricular filling pressures are pathologically elevated ($PCWP > 15-18\text{ mmHg}$ and $CVP > 10-12\text{ mmHg}$). SVR is compensatorily elevated. Cardiac power output ($CPO = [MAP \times CO] / 451$), a robust prognostic metric, drops below $0.6\text{ W}$. Pulmonary venous congestion produces tachypnea, diffuse rales, and hypoxemia.

3. Distributive Shock

Distributive shock is characterized by extensive systemic vasodilation, peripheral arterial and venous pooling, and widespread microvascular endothelial barrier breakdown, resulting in a severe reduction in systemic vascular resistance.

• Septic Shock: Dysregulated host response to infection characterized by profound vasodilation mediated by inducible nitric oxide synthase (iNOS), endothelial activation, and systemic inflammation.
• Anaphylactic Shock: IgE-mediated (or non-IgE direct mast cell degranulation) release of histamine, tryptase, leukotrienes, and platelet-activating factor, triggering catastrophic arteriolar dilation, profound venous pooling, bronchospasm, and rapid transudation of intravascular fluid into interstitial spaces.
• Neurogenic Shock: Interruption of sympathetic vasomotor outflow following traumatic spinal cord injury (typically at or above the T6 level) or high spinal anesthesia. Marked by the classic hemodynamic triad of hypotension, relative bradycardia (loss of cardiac accelerator fibers from T1-T4 preventing compensatory tachycardia), and warm, dry peripheries.
• Endocrine Shock: Acute adrenocortical insufficiency (Addisonian crisis, Waterhouse-Friderichsen syndrome) with absolute or relative lack of cortisol, causing loss of vascular responsiveness to endogenous catecholamines and down-regulation of alpha-1 receptors; or severe myxedema coma.
• Hemodynamic Profile: Systemic vascular resistance is severely depressed ($SVR < 700-800\text{ dynes}\cdot\text{sec}\cdot\text{cm}^{-5}$). In the early hyperdynamic phase ("warm shock"), cardiac output and cardiac index are elevated ($CI > 4.0\text{ L/min/m}^2$) with a widened pulse pressure ($> 40-50\text{ mmHg}$) and bounding peripheral pulses. Central filling pressures (CVP, PCWP) are normal or low due to increased venous capacitance and capillary leakage.

4. Obstructive Shock

Obstructive shock results from physical, extracardiac impedance to the flow of blood into or out of the heart or great vessels, leading to profound reduction in stroke volume.

• Massive Pulmonary Embolism: Sudden mechanical occlusion of $> 50\%$ of the pulmonary arterial bed, abruptly escalating right ventricular afterload. The thin-walled right ventricle dilates acutely, the interventricular septum shifts leftward during diastole (septal flattening or D-shaped left ventricle on echocardiography), and LV diastolic filling is mechanically compromised (ventricular interdependence). Hemodynamics show high CVP, severely elevated pulmonary artery pressures, low PCWP, and depressed cardiac output.
• Cardiac Tamponade: Accumulation of pericardial fluid under tension exceeding intracardiac chamber pressures. Compression of all four cardiac chambers restricts diastolic filling. Hemodynamics reveal equalization of end-diastolic pressures: right atrial pressure, RV end-diastolic pressure, pulmonary artery diastolic pressure, and PCWP equalize within $1-3\text{ mmHg}$. Diagnostic physical signs include Beck's triad (hypotension, jugular venous distension, muffled heart sounds) and pulsus paradoxus (an inspiratory decrease in systolic arterial pressure $> 10\text{ mmHg}$).
• Tension Pneumothorax: Progressive accumulation of air in the pleural space creates high intrapleural positive pressure, causing ipsilateral lung collapse, compression of the superior and inferior vena cava, shift of the mediastinum to the contralateral hemithorax, and cessation of venous return. Exam shows unilateral absent breath sounds, hyperresonance to percussion, tracheal deviation away from the affected side, and marked jugular venous distension.

---

Hemodynamic Profiles Across Shock Categories

---

Cellular Metabolic Crisis: Lactate Pathophysiology

Serum lactate is the primary clinical biomarker used to gauge resuscitation and cellular metabolic stress. Normal physiological serum lactate concentration is less than $1.0\text{ mmol/L}$ in non-stressed individuals, with levels $> 2.0\text{ mmol/L}$ defining hyperlactatemia in the critically ill.

Historically categorized by Cohen and Woods in 1976, lactic acidosis is divided into Type A and Type B:

                             Lactic Acidosis
                                    │
         ┌──────────────────────────┴──────────────────────────┐
         ▼                                                     ▼
      Type A                                                Type B
(Tissue Hypoxia & Hypoperfusion)                      (Non-Hypoperfusion Etiologies)
  • Cardiogenic Shock                                   • Type B1: Liver failure, malignancy
  • Hypovolemic Shock                                   • Type B2: Epinephrine, metformin, linezolid
  • Obstructive Shock                                   • Type B3: Thiamine deficiency, inborn errors
  • Mesenteric / Limb Ischemia
  • Severe Carbon Monoxide Toxicity

Type A Lactic Acidosis (Tissue Hypoxia and Hypoperfusion)

Type A lactic acidosis occurs when cellular oxygen supply falls below $\text{DO}_{2\text{crit}}$. In the absence of oxygen to serve as the terminal electron acceptor in the mitochondrial electron transport chain, oxidative phosphorylation halts, and electrons accumulate in NADH, increasing the intracellular $\text{NADH}/\text{NAD}^+$ ratio. To sustain anaerobic ATP production via glycolysis, the cytosolic enzyme lactate dehydrogenase (LDH) reduces pyruvate to L-lactate, regenerating $\text{NAD}^+$:

$\text{Pyruvate} + \text{NADH} + \text{H}^+ \xrightleftharpoons{\text{LDH}} \text{L-Lactate} + \text{NAD}^+$

While anaerobic glycolysis yields only 2 moles of ATP per mole of glucose (compared to 36 moles generated by complete aerobic oxidation), it preserves immediate survival. Clinical causes of Type A lactic acidosis include all forms of hypoperfusion shock, localized tissue ischemia (acute mesenteric infarction, compartment syndrome, ischemic bowel, limb gangrene), severe carbon monoxide toxicity, and methemoglobinemia.

Type B Lactic Acidosis (Non-Hypoperfusion Mechanisms)

Type B lactic acidosis develops in the absence of overt systemic hypoperfusion or cellular hypoxia and is subdivided into three categories:

• Type B1 (Underlying Systemic Illness): Severe hepatic insufficiency or cirrhosis diminishes the metabolic clearance of lactate via the Cori cycle (gluconeogenesis in hepatocytes clears $70\%$ of circulating lactate; the renal cortex clears $20-30\%$). Severe hematologic malignancies (lymphoma, leukemia) generate high lactate via the Warburg effect—aerobic glycolysis driven by upregulated hexokinase and glucose transporter activity in neoplastic cells.
• Type B2 (Drugs, Toxins, and Medications):
  • Epinephrine Infusion: Epinephrine is a potent agonist of skeletal muscle $\beta_2$-adrenergic receptors. $\beta_2$ activation stimulates membrane-bound adenylate cyclase, elevating intracellular cyclic AMP (cAMP). This initiates a phosphorylation cascade that accelerates glycogen phosphorylase and phosphofructokinase, resulting in intense glycogenolysis and glycolysis. Pyruvate production outstrips the maximum catalytic capacity of mitochondrial pyruvate dehydrogenase (PDH), shunting the excess pyruvate to lactate. This "aerobic hyperlactatemia" occurs despite normal or elevated cardiac output, normal tissue oxygen delivery, and improving organ perfusion metrics.
  • Metformin Toxicity: Metformin inhibits complex I of the mitochondrial respiratory chain and blocks hepatic lactate gluconeogenesis. In the presence of acute kidney injury or severe dehydration, toxic accumulation triggers severe Type B lactic acidosis with an extraordinarily high anion gap.
  • Linezolid and Nucleoside Reverse Transcriptase Inhibitors (NRTIs): Linezolid binds to bacterial 50S ribosomal subunits but shares cross-reactivity with human mitochondrial ribosomes, disrupting mitochondrial protein synthesis and inducing lactic acidosis after prolonged exposure.
  • Propofol Infusion Syndrome (PRIS): High-dose propofol ($> 4-5\text{ mg/kg/h}$ for $> 48\text{ hours}$) impairs mitochondrial entry of long-chain fatty acids and uncouples oxidative phosphorylation, presenting with severe metabolic acidosis, rhabdomyolysis, hyperkalemia, hepatomegaly, and refractory myocardial failure.
• Type B3 (Inborn Errors of Metabolism and Nutritional Deficiencies): Thiamine (vitamin $B_1$) deficiency impairs the activity of thiamine pyrophosphate (TPP)-dependent enzymes, including the pyruvate dehydrogenase multienzyme complex and alpha-ketoglutarate dehydrogenase. When PDH cannot convert pyruvate into acetyl-CoA to enter the Krebs cycle, pyruvate is diverted into lactate. This can manifest as acute high-output shock with severe lactic acidosis ("wet beriberi" or Shoshin beriberi) in malnourished patients, alcohol use disorder, or following bariatric surgery.

---

Microvascular Dysfunction, Glycocalyx Shedding & Macro-Micro Uncoupling

One of the most consequential insights in modern shock physiology is the dissociation or "uncoupling" between systemic macro-hemodynamics and microvascular tissue perfusion, particularly in septic and distributive shock.

The microcirculation consists of arterioles, capillaries (diameter $< 10\ \mu\text{m}$), and post-capillary venules. The luminal surface of healthy vascular endothelium is coated by the endothelial glycocalyx, a dense, gel-like layer $0.5$ to $3.0\ \mu\text{m}$ thick composed of membrane-bound proteoglycans (syndecans, glypicans), glycosaminoglycans (heparan sulfate, chondroitin sulfate), and adsorbed plasma proteins (albumin, antithrombin). The intact glycocalyx performs vital homeostatic functions:

1. Maintains the vascular permeability barrier, restricting the transvascular movement of albumin and fluid.
2. Transduces fluid shear stress into endothelial nitric oxide (eNOS) production, maintaining homeostatic vasodilation.
3. Prevents pathological leukocyte marginization and microvascular platelet aggregation.

In severe shock states (particularly sepsis, major trauma, ischemia-reperfusion, and acute hyperglycemia), inflammatory cytokines (TNF-$\alpha$, IL-1$\beta$), reactive oxygen species, and bacterial endotoxin activate endogenous shedding enzymes (heparanases, hyaluronidases, and matrix metalloproteinases). Circulating levels of syndecan-1 and heparan sulfate surge, serving as biomarkers of severe glycocalyx degradation. Furthermore, iatrogenic hypervolemia and rapid crystalloid infusion cause atrial natriuretic peptide (ANP) release, which directly accelerates glycocalyx shedding.

Glycocalyx degradation induces severe pathophysiological derangements:

• Increased Microvascular Permeability: Capillary leak causes fluid extravasation into the interstitium, generating tissue edema that increases the diffusion distance between capillaries and parenchymal cells.
• Microthrombi and Capillary Plugging: Loss of glycocalyx-bound antithrombin promotes localized microvascular thrombosis, while activated, rigid neutrophils obstruct capillary lumens.
• Loss of Autoregulation and Heterogeneous Perfusion: Direct visualization of the sublingual microcirculation using handheld sidestream dark-field (SDF) or incident dark-field (IDF) imaging reveals severe microcirculatory heterogeneity. Functional capillary density decreases; hyperemic, fast-flowing capillaries coexist directly adjacent to plugged or non-flowing microvessels.

As a consequence of this microvascular uncoupling, achieving standard macro-hemodynamic targets—such as a mean arterial pressure (MAP) $\ge 65\text{ mmHg}$ or a normal cardiac index—does not ensure restored organ parenchymal oxygenation. Clinicians must combine macrocirculatory metrics with dynamic indicators of tissue perfusion, including capillary refill time, serum lactate clearance kinetics, and central venous oxygen saturation.